|
|
|
|
| LEADER |
01848cam a2200481 4500 |
| 001 |
PPN058936742 |
| 005 |
20220126060200.0 |
| 010 |
|
|
|a 2-84299-285-7
|b rel.
|d 60.00 EUR
|
| 010 |
|
|
|a 2-84299-284-9
|b br.
|d 38 EUR : 249,26 F
|
| 035 |
|
|
|a DYNIX_BUFDF_144772
|
| 035 |
|
|
|a frBN026805427
|
| 035 |
|
|
|a bua133548
|
| 035 |
|
|
|a elec2001310930
|
| 035 |
|
|
|a (OCoLC)421915848
|
| 073 |
|
0 |
|a 9782842992842
|b br.
|
| 100 |
|
|
|a 20011120h20012001k y0frey0103 ba
|
| 101 |
0 |
|
|a fre
|f fre
|g fre
|
| 102 |
|
|
|a FR
|
| 105 |
|
|
|a a a 001yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a La nouvelle économie industrielle de la pharmacie
|b Texte imprimé
|e structures industrielles, dynamique d'innovation et stratégies commerciales
|f Abdelillah Hamdouch, Marc-Hubert Depret
|
| 210 |
|
|
|a Paris
|a Amsterdam
|a New York [etc]
|c Elsevier
|d DL 2001
|e 75-Paris
|g Impr. Stedi
|
| 215 |
|
|
|a 1 vol. (XVI-280 p.)
|c tabl., graph., couv. ill. en coul.
|d 24 cm
|
| 225 |
2 |
|
|a Biocampus
|x 1623-0884
|
| 320 |
|
|
|a Bibliogr. p. 233-255. Glossaire. Index
|
| 410 |
|
| |
|0 053130804
|t Biocampus (Paris)
|x 1623-0884
|
| 606 |
|
|
|3 PPN040696820
|a Industrie pharmaceutique
|2 fmesh
|
| 606 |
|
|
|3 PPN040825035
|a Pharmacoéconomie
|2 fmesh
|
| 606 |
|
|
|3 PPN027424162
|a Biopharmacie
|2 rameau
|
| 606 |
|
|
|3 PPN050363654
|a Pharmacoéconomie
|2 rameau
|
| 606 |
|
|
|3 PPN027373304
|a Biotechnologie
|3 PPN028644905
|x Aspect économique
|2 rameau
|
| 606 |
|
|
|3 PPN027292630
|a Industrie pharmaceutique
|2 rameau
|
| 675 |
|
|
|a 33
|v Éd. 1967
|
| 676 |
|
|
|a 338.4
|v 21
|z fre
|
| 676 |
|
|
|a 615.068
|
| 680 |
|
|
|a HF5439.D75
|
| 686 |
|
|
|a QV 736
|2 usnlm
|
| 700 |
|
1 |
|3 PPN02992538X
|a Hamdouch
|b Abdelillah
|f 1957-....
|4 070
|
| 701 |
|
1 |
|3 PPN059179287
|a Depret
|b Marc-Hubert
|f 1976-....
|4 070
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20101123
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b BN
|g AFNOR
|
| 930 |
|
|
|5 441842201:199087199
|b 441842201
|a 338.4 HAM
|j u
|
| 998 |
|
|
|a 373953
|
Nantilus
